Aperio Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Aperio Group’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$417K	Buy	9,629 +2,053	+27%	+$101K	﹤0.01%	2045
2020 Q3	$418K	Buy	7,576 +999	+15%	+$63.5K	﹤0.01%	1911
2020 Q2	$415K	Buy	6,577 +1,112	+20%	+$76.3K	﹤0.01%	1864
2020 Q1	$279K	Buy	5,465 +254	+5%	+$17K	﹤0.01%	1947
2019 Q4	$414K	Buy	5,211 +223	+4%	+$13.2K	﹤0.01%	1911
2019 Q3	$242K	Sell	4,988 -517	-9%	-$26.9K	﹤0.01%	2102
2019 Q2	$290K	Buy	+5,505	New	+$316K	﹤0.01%	2039

Other funds holding GBT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aperio Group's GBT Position: Q4 2020 in Review

Aperio Group increased its Global Blood Therapeutics, Inc. (GBT) stake by 27% in Q4 2020, buying an estimated $101K and bringing the position to 9,629 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #2045.

Aperio Group first reported a position in GBT in Q2 2019 and has held it in 7 quarters since. The position peaked at $418K in Q3 2020. 228 funds tracked by Wall St. Rank hold GBT as of Q4 2020.

Aperio Group held 9,629 shares of Global Blood Therapeutics, Inc. worth $417K as of Q4 2020.
Aperio Group bought 2,053 Global Blood Therapeutics, Inc. shares in Q4 2020, an estimated $101K.
Global Blood Therapeutics, Inc. made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2045 holding.
Aperio Group first reported a position in Global Blood Therapeutics, Inc. in Q2 2019 and has held it in 7 quarters since.
Aperio Group's Global Blood Therapeutics, Inc. position peaked at $418K in Q3 2020.
228 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.